Smith & Nephew's U.S. Orthopedics Strength Looks Reassuring -- Market Talk

Dow Jones

Apr 30, 2025

0809 GMT - Smith & Nephew's continuing strength in U.S. orthopedics is reassuring, RBC Capital Markets analyst Jack Reynolds-Clark says in a research note. The U.K. medical-technology company posted first-quarter revenue in line with consensus expectations, with underlying growth ahead of views albeit a greater-than-expected impact of currency fluctuations, the analyst says. As expected, the performance in China was a significant headwind in the quarter, the analyst adds. "The results demonstrate continued strength in U.S. Orthopaedics and Sports Medicine and incrementally de-risk expectations for the full year 2025," the analyst says. Shares are up 5.1% at 1,050.50 pence. (maitane.sardon@wsj.com)

(END) Dow Jones Newswires

April 30, 2025 04:09 ET (08:09 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2531709539"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2531709539\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2531709539?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-30 16:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2531709539","market":"nz","top_or_hot":-1,"title":"Smith & Nephew's U.S. Orthopedics Strength Looks Reassuring -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0809 GMT - Smith &amp; Nephew's continuing strength in U.S. orthopedics is reassuring, RBC Capital Markets analyst Jack Reynolds-Clark says in a research note. The U.K. medical-technology company posted first-quarter revenue in line with consensus expectations, with underlying growth ahead of views albeit a greater-than-expected impact of currency fluctuations, the analyst says. As expected, the performance in China was a significant headwind in the quarter, the analyst adds. \"The results demonstrate continued strength in U.S. Orthopaedics and Sports Medicine and incrementally de-risk expectations for the full year 2025,\" the analyst says. Shares are up 5.1% at 1,050.50 pence. (maitane.sardon@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 30, 2025 04:09 ET (08:09 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Smith & Nephew's U.S. Orthopedics Strength Looks Reassuring -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSmith & Nephew's U.S. Orthopedics Strength Looks Reassuring -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-04-30 16:09</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0809 GMT - Smith &amp; Nephew's continuing strength in U.S. orthopedics is reassuring, RBC Capital Markets analyst Jack Reynolds-Clark says in a research note. The U.K. medical-technology company posted first-quarter revenue in line with consensus expectations, with underlying growth ahead of views albeit a greater-than-expected impact of currency fluctuations, the analyst says. As expected, the performance in China was a significant headwind in the quarter, the analyst adds. \"The results demonstrate continued strength in U.S. Orthopaedics and Sports Medicine and incrementally de-risk expectations for the full year 2025,\" the analyst says. Shares are up 5.1% at 1,050.50 pence. (maitane.sardon@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 30, 2025 04:09 ET (08:09 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2531709539","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2531709539","pubTimestamp":1746000540,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0809 GMT - Smith & Nephew's continuing strength in U.S. orthopedics is reassuring, RBC Capital Markets analyst Jack Reynolds-Clark says in a research note. The U.K. medical-technology company posted first-quarter revenue in line with consensus expectations, with underlying growth ahead of views albeit a greater-than-expected impact of currency fluctuations, the analyst says. As expected, the performance in China was a significant headwind in the quarter, the analyst adds. \"The results demonstrate continued strength in U.S. Orthopaedics and Sports Medicine and incrementally de-risk expectations for the full year 2025,\" the analyst says. Shares are up 5.1% at 1,050.50 pence. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","SNN":"Smith & Nephew PLC ADS"},"translate_title":"施乐辉在美国骨科的实力看起来令人放心——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SNN":0.9},"content_text":"0809 GMT - Smith & Nephew's continuing strength in U.S. orthopedics is reassuring, RBC Capital Markets analyst Jack Reynolds-Clark says in a research note. The U.K. medical-technology company posted first-quarter revenue in line with consensus expectations, with underlying growth ahead of views albeit a greater-than-expected impact of currency fluctuations, the analyst says. As expected, the performance in China was a significant headwind in the quarter, the analyst adds. \"The results demonstrate continued strength in U.S. Orthopaedics and Sports Medicine and incrementally de-risk expectations for the full year 2025,\" the analyst says. Shares are up 5.1% at 1,050.50 pence. (maitane.sardon@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 30, 2025 04:09 ET (08:09 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}